Introduction to Her2 Targeted Therapy In Early Breast Cancer
Exploring Her2 Targeted Therapy In Early Breast Cancer reveals several interesting facts. Panelists Adam M. Brufsky, MD, PhD; Michael Untch, MD; and Ahmad Awada, MD, PhD, discuss the role and use of ...
Her2 Targeted Therapy In Early Breast Cancer Comprehensive Overview
Variables that clinicians should consider when selecting an appropriate Moderator, Debu Tripathy, MD, introduces the panel for a unique discussion that features peer-to-peer expert exchange, ... Panelists Adam M. Brufsky, MD, PhD; Kimberly L. Blackwell, MD; Mark E. Robson, MD; and Aditya Bardia, MD, MPH, highlight the ...
... live from MGH studios today's discussion will be focused on treatment of
Summary & Highlights for Her2 Targeted Therapy In Early Breast Cancer
- HER2
- Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, reflects on the expanding treatment landscape of ...
- An overview of the APHINITY trial in
- Ruth O'Regan, MD, reviews the case of a 49-year-old female patient with
- Sarah A. Hurvitz, MD, explores the history of
Stay tuned for more updates related to Her2 Targeted Therapy In Early Breast Cancer.